会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 74. 发明公开
    • Unsaturated fatty acid derivatives and their production
    • UngesättigteFettsäurederivateund deren Herstellung。
    • EP0183177A1
    • 1986-06-04
    • EP85114733.0
    • 1985-11-19
    • SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
    • Nakamura, ToshioMuraoka, MasamiOno, KeiichiYamamoto, Michihiro
    • C07C103/56C07C103/30A61K31/16C07D295/18A61K31/23A61K31/19C07C69/732C07C69/734C07C59/42C07C59/46
    • C07D295/185C07C59/42C07C59/46C07D309/12
    • A compound of the formula:
      wherein Y is a free or esterified carboxyl group, or a group of the formula:
      (wherein R a and R b are each independently a hydrogen atom, a C 1 -C 4 alkyl group, a C 3 -C 7 cycloalkyl group, a benzyl group, a phenyl group, a phenyl group substituted with a halogen atom or a C 1 -C 4 alkyl group, or, when taken together with the adjacent nitrogen atom, they represent a 5 to 7 membered saturated heterocyclic goup); R' is a C 1 -C 12 alkyl group, a C 2 -C 12 alkenyl group, a C 2 -C 12 alkynyl group, a C 3 -C 10 cycloalkyl group, a C 4 -C 10 cycloalkenyl group, a hydroxy C 1 -C 13 alkyl group, an C 1 -C 12 alkyl group substituted with a group of the formula:
      (wherein R c and R d are each independently a hydrogen atom, or a C,-C 4 alkyl group), a C 3 -C 10 heterocyclic group, a phenyl group optionally substituted with one to three substituents selected from the group consisting of halogen atom, hydroxyl group, C 1 -C 4 alkyl group, trifluoromethyl group, C 1 -C 4 alkoxy group, and group of the formula:
      (wherein R c and R d are as defined above) or a group of the formula:
      [wherein A is a C 1 -C 7 alkylene chain and B is a C 3 -C 10 cycloalkyl group, a C 4 -C 10 cycloalkenyl group, a C 1 -C 12 alkoxy group, a C 1 -C 12 alkylthio group, a C 3 -C 10 cycloalkoxy group, a C 4 -C 10 cycloalkenyloxy group, a C 3 -C 10 heterocyclic group, or a phenyl or phenoxy group optionally substituted with one to three substituents selected from the group consisting of halogen atom, hydroxy group, C 1 -C 4 alkyl group, group of the formula:
      (wherein R c and R d are as defined above), trifluoromethyl group, C 1 -C 4 alkylthio group and C,-C 4 alkoxy group]; n is 2, 3 or 4; R 2 and R 3 are hydrogen atoms or, when taken together, they mean a single linkage to form a trans double bond between the adjacent carbon atoms, and E is a cis or trans vinylene group; provided that when n is 3 and R' is a n-octyl group, a 2-octenyl group or a 2,5-octadienyl group, R 2 and R 3 are hydrogen atoms, and that when n is 2, E is a trans vinylene group or a non-toxic pharmaceutically acceptable salt thereof. Said compound have potent anti-leucotriene B 4 action, and are useful in the treatment of inflammation and allergy.
    • 下式的化合物:其中Y是游离或酯化的羧基,或下式的基团:其中R a和R b各自独立地为氢原子,C1- C4烷基,C3-C7环烷基,苄基,苯基,被卤素原子或C1-C4烷基取代的苯基,或者当与相邻的氮原子一起时,它们代表5 至7元饱和杂环苷); R 1是C 1 -C 12烷基,C 2 -C 12烯基,C 2 -C 12炔基,C 3 -C 10环烷基,C 4 -C 10环烯基,羟基C 1 -C 13烷基,C 1 被下式基团取代的-C 12烷基:其中R c和R d各自独立地为氢原子或C 1 -C 4烷基,C 3 -C 10杂环基, 任选被一至三个选自卤素原子,羟基,C 1 -C 4烷基,三氟甲基,C 1 -C 4烷氧基的取代基取代的苯基,和下式基团:其中R c >和R d如上定义)或下式的基团:AB [其中A是C 1 -C 7亚烷基链,B是C 3 -C 10环烷基,C 4 -C 10环烯基,C 1 -C 12 烷氧基,C1-C12烷硫基,C3-C10环烷氧基,C4-C10环烯基氧基,C3-C10杂环基或苯基或苯氧基,任选被一至三个选自 由卤素原子,羟基,C 1 -C 4烷基组成的基团,其结构式为:CHEM(其中R c和R d如上所定义),三氟甲基,C 1 -C 4烷硫基和C 1 -C4烷氧基]; n为2,3或4; R 2和R 3是氢原子,或者当它们一起表示单键以在相邻碳原子之间形成反式双键时,E是顺式或反式亚乙烯基; 条件是当n为3且R 1为正辛基,2-辛烯基或2,5-辛二烯基时,R 2和R 3为氢原子,当n为 2,E是反式亚乙烯基或其无毒的药学上可接受的盐。 所述化合物具有有效的抗白三烯B4作用,并且可用于治疗炎症和变态反应。
    • 75. 发明公开
    • 13-Aza-14-oxo-txa2 analogues
    • 13氮杂-14-氧代 - TXA2类似物。
    • EP0171146A1
    • 1986-02-12
    • EP85304148.1
    • 1985-06-12
    • ONO PHARMACEUTICAL CO., LTD.
    • Miyake, HajimuOkegawa, TadaoKawasaki, Akiyoshi
    • C07C103/38C07C103/42C07C103/30C07C103/46C07C149/32C07C149/26C07C125/065C07C127/15C07C177/00C07C103/00A61K31/00
    • C07D209/18C07C33/14C07C51/367C07C59/11C07C405/0091
    • A novel 13-aza-14-oxo-TXA 2 analogue of general formula:
      [wherein symbol A represents

      (i) a group of general formula: -CH 2 CH 2 -(CH 2 ) m -,
      (ii)) a group of general formula: cis-CH=CH-(CH 2 ) 17 ,
      (iii) a group of general formula: -CH 2 O-(CH 2 ) m -,
      (iv) a group of general formula: -S-(CH 2 ) m -(wherein m represents an integer of from 1 to 6) or
      (v) a group of general formula: -


      R 1 represents a hydrogen atom or a straight or branched alkyl group of from 1 to 12 carbon atom(s);
      R 2 represents a bond or a straight or branched alkylene or alkylene group of from 1 to 10 carbon atom(s) unsubstituted or substituted by at least one of hydroxy group, amino group, halogen atom or phenylthio group;
      R 3 represents
      (i) a phenyl, phenoxy or phenylthio group unsubstituted or substituted by at least one of straight or branched alkyl or alkoxy group of from 1 to 6 carbon atom(s), halogen atom or hydroxy group,
      (ii) a straight or branched alkyl, alkenyl or alkynyl group of from 1 to 6 carbon atom(s) unsubstituted or substituted by at least one of halogen atom or hydroxy group,
      (iii) a cycloalkyl, cycloalkyloxy or cycloalkylthio group of from 4 to 7 carbon atoms unsubstituted or substituted by at least one of straight or branched alkyl group of from 1 to 6 carbon atom(s), halogen atom or hydroxy group,
      (iv) a naphthyl, indolyl or indanyl group, or
      (v) an amino group unsubstituted or substituted by at least one of straight or branched alkyl group of from 1 to 6 carbon atom(s); and
      R 4 represents a hydrogen atom or a methyl group.
      With proviso that, the carbon atom neighbored with R 3 in R 2 should have no substituents, when R 3 represents a phenyloxy, phenylthio, cycloalkyloxy or cycloalkylthio group unsubstituted or substituted.]
      and cyclodextrin clathrates thereof and non-toxic salts thereof wherein R' represents a hydrogen atom possess an antagonistic activity on TXA 2 , in particular, inhibit blood platelet aggregation and contraction of artery, and are, therefore, useful for prevention and/or treatment of inflammation, hypertension, thrombus, cerebral apoplexy, asthma, cardiac infarction, angina pectoris, cerebral infarction and death by acute cardiac diseases in mammals, in particular in humans, which are induced by thromboxane A 2 .
    • 78. 发明公开
    • Fluorine-containing compounds
    • 荧光黄酮
    • EP0144844A2
    • 1985-06-19
    • EP84113916.5
    • 1984-11-16
    • DAIKIN INDUSTRIES, LIMITED
    • Hisamoto, IwaoYamana, Masayuki
    • C07C103/30C07C91/12C07C103/44C07C143/74C07C143/63C07C87/30C07C93/02
    • B01F17/0064B01D19/0413B01F17/0042B01F17/0057B01D19/0418B01D19/0422B01D19/0427
    • A fluorine-containing compound of the formula:
      wherein

      R, is a C 3 -C 21 fluorinated hydrocarbon group or a C 3 -C 2 , fluorinated oxyhydrocarbon group;
      X' is a C 1 -C 11 hydrocarbon group;
      X 2 , X 3 and X 4 are each a C 2 -C 6 hydrocarbon group;
      Y 1 is a group of the formula:

      Y 2 is a group of the formula:

      W 1 is a group of the formula:

      W 2 is a C 1 -C 10 hydrocarbon group optionally having -OH or -COOH or a amide group in the backbone;
      Z 1 is halogen or a group of the formula:

      Z 2 is a group of the formula:

      Z 3 is a group of the formula:


      R 1 is hydrogen or a C 1 -C 5 hydrocarbon group;
      R 2 is hydrogen or a C 2 -C 4 acyl group;
      R 3 is hydrogen or a group of the formula: -(X 1 O) q H or -R 7 Z 3 ;
      R 4 is a group of the formula: -(X 1 O) q H or -R 7 Z 3 ;
      R 5 and R 6 are each a C 1 -C 20 hydrocarbon group or a group of the formula:
      -(X 1 O) q H, -X 1 k COOM, -R, or -Y 1 X 1 k R f ;
      R 7 is a C 1 -C 20 hydrocarbon group or a group of the formula: -(CH 2 CH 2 OCH 2 CH 2 ) r -;
      R 8 , R 9 and R 10 are each a C 1 -C 20 hydrocarbon group or a group of the formula:
      -(X 1 O) q H, -R f or -Y 1 X 1 k R f ;
      R" is C 2 -C 6 alkylene group optionally having one or two oxygen or sulfur atoms;
      R 12 is hydrogen, a C 1 -C 20 hydrocarbon group or a C 2 -C 20 acyl group;
      R 13 is hydrogen or a C 1 -C 20 hydrocarbon group;
      M is hydrogen, an alkali metal, an alkaline earth metal or a NH 4 group;
      k is zero or one;
      m is an integer of 1 to 50;
      n is an integer of 1 to 5;
      q is an integer of 1 to 20; and
      r is an integer of 1 to 5.
    • 一种下式的含氟化合物:其中R f为C 3 -C 21氟化烃基或C 3 -C 21氟代羟基烃基; X 1是C 1 -C 11烃基; X 2,X 3和X 4各自为C 2 -C 6烃基; Y 1是下式的基团:CH 2 CH 2是下式的基团: W 1是下式的基团: W 2是C 1 -C 10烃基 在骨架中任选具有-OH或-COOH或酰胺基; Z 1是卤素或下式的基团:CHEM> Z 2是下式的基团:CH 2 CH 3 Z 3是下式的基团: -COOM,-SO 3 M,-OSO 3 M,-O(OM)2或CHEM R 1是氢或C 1 -C 5烃基; R 2是氢或C 2 -C 4酰基; R 3是氢或下式的基团: - (X 1 O)q H或-R 7 Z 3; R 4是下式的基团: - (X 1 O)q H或-R 7 Z 3; R 5和R 6各自为C 1 -C 20烃基或下式基团: - (X 1 O)q H,-X 1 kCOOM,-R f或-Y 1 X 1 kR f; R 7是C 1 -C 20烃基或下式的基团: - (CH 2 CH 2 OCH 2 CH 2)r - ; R 8,R 9和R 1各自为C 1 -C 20烃基或下式基团: - (X 1 O)q H,-R f或-Y 1 X <1>的KrF; R 1是任选具有一个或两个氧或硫原子的C 2 -C 6亚烷基; R 1是氢,C 1 -C 20烃基或C 2 -C 20酰基; R 1是氢或C 1 -C 20烃基; M是氢,碱金属,碱土金属或NH 4基; k为零或一; m为1〜50的整数。 n为1〜5的整数, q为1〜20的整数, r为1〜5的整数
    • 79. 发明公开
    • Acrylsäureamide, ihre Herstellung und Verwendung
    • 丙烯酰胺,其制备方法和用途。
    • EP0120321A1
    • 1984-10-03
    • EP84102012.6
    • 1984-02-27
    • Shell Agrar GmbH & Co. KG
    • Nickl, Josef, Dr. Dipl.-Chem.Pieper, Helmut, Dr. Dipl.-Chem.Curtze, Jürgen, Dr. Dipl.-Chem.Drandarevski, Christo, Dr.Lust, Sigmund, Dr.
    • C07D295/18C07C103/30C07D265/30C07D317/60C07D213/56C07D307/54C07D333/24C07D295/22
    • C07D295/185A01N37/10A01N37/34A01N37/38A01N37/44A01N37/46A01N37/48C07C45/46C07C59/64C07C205/45C07D213/56C07D295/194C07D295/32C07D307/54C07D317/60C07D333/24C07C49/84
    • Die Verbindungen der Formel Doppelkeg
      in der A für die Gruppe
      B für die Gruppe
      Q für eine der Gruppen
      und
      X für 0, 5 oder NH, für einen gegebenenfalls substituierten Rest aus der Gruppe Alkyl-Alkenyl, -Cycloalkyl, -Cycloalkenyl, Pyridyl, Furyl,
      Thienyl, α-und β-Naphthyl; oder zusammen mit der Gruppe CR 5 für einen
      cycloaliphatischen Rest, an den ein Benzolring ankondensiert sein kann; oder für den Rest
      steht, wobei

      k die Zahlen 0, 1 oder 2,
      m die Zahlen 1, 2, 3 oder 4,
      n die Zahlen 0 oder 1,
      R, Wasserstoff, C 1 -C 5 -Alkyl, Cyano und, wenn k gleich 0 ist, auch Chlor, Brom oder Jod,
      R 2 und R 11 Wasserstoff, Halogen, Nitro, gegebenenfalls substituiertes -Alkyl oder -Alkoxy, -Alkinyloxy, Amino, NH( -Alkyl), N( -Alkyl) 2 , Cyano, Phenyl, -Cycloalkyl, -Alkenyloxy, Hydroxy( -Alkyl), NH COR 6 , CO 2 R 6 , CON-R 7 R 8 , durch Sauerstoff unterbrochenes -Alkyl oder

      R 3 , R 4 , R 12 und R 13 Wasserstoff, Halogen, -Alkyl, -Alkoxy, (-Alkyl) -S(0)p (p = 0,1 oder 2), Hydroxy oder (-Acyl)oxy, R 3 /R 4 und R 12 =/R 13 jeweils gemeinsam auch Methylendioxy oder Ethylendioxy, gebunden an zwei Benachbarte Atome des Phenykings,
      R 3 und R 4 Wasserstoff oder -Alkyl, R 5 außerdem, zusammen mit dem C-Atom, an das es gebunden ist, und Y einen cycloaliphatischen Rest, an den ein Benzolring ankondensiert sein kann
      R 7 und R. -Alkyl, -Cycoalkyl, Phenyl, Benzyl, Furfuryl, Tetrahydrofurfuryl oder-Alkenyl, gemeinsam außerdem auch eine -Alkylentette. die durch 0, NR., S(0)q (mit q = 0, 1 oder 2) unterbrochen sein kann, R 7 außerdem Wasserstoff.
      R. und R 16 , die nur vorliegen, wenn R 7 und R 3 gemeinsam eine Kette darstellen, Wasserstoff oder -Alkyl bedeuten, sowie gegebenenfalls die Säureadditionssalze der vorstehend defineirten Verbindungen, haben insbesondere fungizide Wirkung gegen phytopathogene Pilze.

      Die Herstellung und Formulierung der Verbindungen erfolgt nach konventionellen Methoden.
    • 式Doppelkeg 其中A是该组的组 B的化合物Y-(CR5 = CR6)K(III)中,Q表示的基团之一 X是0,5或NH用于 任选被取代的选自烷基烯基,环烷基,环烯基,吡啶基,呋喃基,噻吩基,α和β萘基; 或与CR5组为一个环族基团一起形成一个苯环可以稠合; 或表示基团其中,k是数字0,1或2,M的数字1,2,3或4,n中的号码0或1,R1是氢,C1-CA-烷基氰基和,如果k 等于0,也氯,溴或碘,R 2和R 11是氢,卤素,硝基,任选取代的烷基或烷氧基,炔氧基,氨基,NH(烷基),N(烷基)2,氰基,苯基, 环烷基,链烯基,羟基(烷基),NH COR6,O2R6,CON-R7-R8,被氧烷基或 R3,R4,R12和R13是氢,卤素,烷基,烷氧基,(中断 烷基)-S(O)p(p = 0时,1或2),羟基或(酰基)氧基,R3 / R4和R12 / R13在每一种情况下一起是可替换地亚甲二氧基或亚乙二氧基,连接到苯环,R 5的两个相邻原子 并且R6是氢或烷基,R 5还连同碳原子其所连接,并且Y是环脂族基,向其中苯环可以稠合。 R7和R8是烷基,环烷基,苯基,苄基,糠基,四氢糠基或链烯基,也一起由0,NR 6,S(0)将被中断的亚烷基链Q(其中q = 0,1或2) 也可以是氢,R9和R10,仅当R7和R8一起代表一个链,代表氢或烷基,和任选的上述defineirten化合物的酸加成盐具有抗植物病原性真菌特别是杀真菌活性发生R7。 该化合物的制备和制剂根据常规方法进行。